These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16133379)

  • 21. Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.
    Goethals I; Hoste P; De Vriendt C; Smeets P; Verlooy J; Ham H
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):462-7. PubMed ID: 19820931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive and prognostic value of FDG-PET.
    Geus-Oei LF; Oyen WJ
    Cancer Imaging; 2008 Mar; 8(1):70-80. PubMed ID: 18390390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of FDG-PET in differentiating benign from malignant compression fractures.
    Bredella MA; Essary B; Torriani M; Ouellette HA; Palmer WE
    Skeletal Radiol; 2008 May; 37(5):405-13. PubMed ID: 18278491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
    Van de Wiele C; VandeVyver F; Debruyne C; Philippé J; van Meerbeeck JP
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):519-22. PubMed ID: 18034241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.
    Fan C; Hernandez-Pampaloni M; Houseni M; Chamroonrat W; Basu S; Kumar R; Dadparvar S; Torigian DA; Alavi A
    Mol Imaging Biol; 2007; 9(5):300-7. PubMed ID: 17574502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT and MR imaging in myeloma.
    Mulligan ME; Badros AZ
    Skeletal Radiol; 2007 Jan; 36(1):5-16. PubMed ID: 16915386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.
    Kohno S; Furuta A; Arizono S; Tokunaga K; Nakao S; Tanabe M; Kataoka TR; Isoda H; Togashi K
    Jpn J Radiol; 2021 Sep; 39(9):857-867. PubMed ID: 34021462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.
    Kazama T; Swanston N; Podoloff DA; Macapinlac HA
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
    Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
    J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
    Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M
    Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
    Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
    Mayer D; Bednarczyk EM
    Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
    Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls.
    Kazama T; Faria SC; Varavithya V; Phongkitkarun S; Ito H; Macapinlac HA
    Radiographics; 2005; 25(1):191-207. PubMed ID: 15653595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography.
    Takalkar A; Yu JQ; Kumar R; Xiu Y; Alavi A; Zhuang H
    Clin Nucl Med; 2004 Oct; 29(10):637-9. PubMed ID: 15365439
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.